References
- Abiola, T., Udofia, O., & Zakari, M. (2013). Psychometric properties of the 3-item oslo social support scale among clinical students of Bayero University Kano, Nigeria. Malaysian Journal of Psychiatry, 22(2), 32–41. https://www.mjpsychiatry.org/index.php/mjp/article/view/264/0
- Adewuya, A. O., Ologun, Y. A., & Ibigbami, O. S. (2006). Post-traumatic stress disorder after childbirth in Nigerian women: Prevalence and risk factors. BJOG: An International Journal of Obstetrics and Gynaecology, 113(3), 284–288. https://doi.org/https://doi.org/10.1111/j.1471-0528.2006.00861x
- Akinbami, A., Bola, O., Uche, E., Badiru, M., Olowoselu, O., Suleiman, A. M., & Augustine B. (2019). Pentazocine addiction among sickle cell disease patients and perception of its use among health-care workers. Journal of Applied Hematology, 10(3), 94–98. https://doi.org/https://doi.org/10.4103/joah.joah_39_19
- Armiya’u, A. Y., Garba, B. I., & Haliru, D. G. (2016). Intravenous pentazocine dependence in a young sickle cell anemia patient: A case report. Case Reports International, 5, 1–4. https://doi.org/https://doi.org/10.5348/crint-2016-20-CR-1
- Ballas, S. K., Kanter, J., Agodoa, I., Howard, R., Wade, S., Noxon, V., & Dampier, C. (2018). Opioid utilization patterns in United States individuals with sickle cell disease. American Journal of Hematology, 93(10), E345–E347. https://doi.org/https://doi.org/10.1002/ajh.25233
- Bazuaye, G. N., & Uwadiae, E. (2016). Pentazocine dependence among sickle cell disease patients attending out patient specialist sickle cell clinic in Benin City, Nigeria’. Nigerian Journal of Psychiatry, 14(1), 25–29. https://doi.org/https://doi.org/10.4314/njpsycv14i1
- Bediako, S. M., Lanzkron, S., Diener-West, M., Onojobi, G., Beach, M. C., & Haywood, C. (2016). The measure of sickle cell stigma: Initial findings from the improving patient outcomes through respect and trust study. Journal of Health Psychology, 21(5), 808–820. https://doi.org/https://doi.org/10.1177/1359105314539530
- Brokelman, R. B. G., Haverkamp, D., van Loon, C., Hol, A., van Kampen, A., & Veth, R. (2012). The validation of the visual analogue scale for patient satisfaction after total hip arthroplasty. European Orthopaedics and Traumatology, 3(2), 101–105. https://doi.org/https://doi.org/10.1007/s12570-012-0100-3
- Bulgin, D., Tanabe, P., & Jenerette, C. (2018). Stigma of sickle cell disease: A systematic review. Issues in Mental Health Nursing, 39(8), 675. https://doi.org/https://doi.org/10.1080/01612840.2018.1443530
- Kingsley, A., Ofonime, E., Bassey, B., Eberechi, O., Ekang, E., Akaba, E., Adaobi, D., & Godwin, O. (2019). Case report: The effect of pentazocine abuse in a female sickle cell disease patient in calabar, South-south, Nigeria. Journal of Pharmaceutical Research International, 29(5), 1–7. https://doi.org/https://doi.org/10.9734/jpri/2019/v29i530247
- Lee, L., Smith-Whitley, K., Banks, S., & Puckrein, G. (2019). Reducing health care disparities in sickle cell disease: A review. Public Health Reports, 134(6), 599–607. https://doi.org/https://doi.org/10.1177/0033354919881438
- Madu, A. J., Korubo, K., Okoye, H., Ugwu, N., Efobi, C., Nwogoh, B., & Okoye, A. (2018). Survey of Sickle Cell Anaemia Patients: The Perspective of Healthcare Providers. Haematology International Journal. 2(4), 1–8. https://doi.org/https://doi.org/10.23880/hij-16000133
- Nnoli, A., Seligman, N. S., Dysart, K., Baxter, J. K., & Ballas, S. K. (2018). Opioid utilization by pregnant women with sickle cell disease and the risk of neonatal abstinence syndrome. Journal of the National Medical Association, 110(2), 163–168. https://doi.org/https://doi.org/10.1016/j.jnma.2017.04.002
- Ola, B. A., Yates, S. J., & Dyson, S. M. (2016). Living with sickle cell disease and depression in Lagos, Nigeria: A mixed methods study. Social Science & Medicine, 161(1), 27–36. https://doi.org/https://doi.org/10.1016/j.socscimed.2016.05.029
- Sheehan, D. V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G.C. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl 20), 22–33. quiz 34-57. https://www.psychiatrist.com/JCP/article/Pages/mini-international-neuropsychiatric-interview-mini.aspx?sclick=1